1-3 of 3
Authors: Lena Kaiser
Save search
Sort by
Journal Article

Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments Get access

PDF
Katharina J Müller and others
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 77–88, https://doi.org/10.1093/neuonc/noae208
Published: 19 November 2024
Journal Article

NIMG-48. MEASURABLE DISEASE AS BASELINE CRITERION FOR RESPONSE ASSESSMENT IN GLIOBLASTOMA TRIALS – A COMPARATIVE STUDY OF MRI-BASED (RANO 2.0) VERSUS PET-BASED (PET RANO 1.0) ASSESSMENT

PDF
Katharina Johanna Müller and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii206, https://doi.org/10.1093/neuonc/noae165.0812
Published: 11 November 2024
Journal Article

NIMG-26. UPTAKE OF [18F]GE-180 IN TSPO PET IS ASSOCIATED WITH SURVIVAL IN PATIENTS WITH RECURRENT GLIOMA

PDF
Stefanie Quach and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii167–vii168, https://doi.org/10.1093/neuonc/noac209.644
Published: 14 November 2022